Hayk Davtyan, Ph.D.
Affiliations: | 2017- | MIND | University of California, Irvine, Irvine, CA |
Area:
Alzheimer's disease, NeuroimmunologyGoogle:
"Hayk Davtyan"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Agadjanyan G. Michael | post-doc | 2008-2011 | Institute for Molecular Medicine |
| Carl W. Cotman | post-doc | 2011-2013 | UC Irvine |
| Mathew M. Blurton-Jones | research scientist | 2017- | UC Irvine |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Granzotto A, McQuade A, Chadarevian JP, et al. (2024) ER and SOCE Ca signals are not required for directed cell migration in human microglia. Biorxiv : the Preprint Server For Biology |
| Haukedal H, Syshøj Lorenzen S, Winther Westi E, et al. (2023) Alteration of microglial metabolism and inflammatory profile contributes to neurotoxicity in a hiPSC-derived microglia model of frontotemporal dementia 3. Brain, Behavior, and Immunity. 113: 353-373 |
| Chadarevian JP, Davtyan H, Lombroso SI, et al. (2023) CRISPR generation of CSF1R-G795A human microglia for robust microglia replacement in a chimeric mouse model. Star Protocols. 4: 102490 |
| Liu Z, Chao J, Wang C, et al. (2023) Astrocytic response mediated by the CLU risk allele inhibits OPC proliferation and myelination in a human iPSC model. Cell Reports. 42: 112841 |
| Kim C, Hovakimyan A, Zagorski K, et al. (2023) Author Correction: Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies. Npj Vaccines. 8: 105 |
| Zagorski K, King O, Hovakimyan A, et al. (2023) Novel Vaccine against Pathological Pyroglutamate-Modified Amyloid Beta for Prevention of Alzheimer's Disease. International Journal of Molecular Sciences. 24 |
| McQuade A, Kang YJ, Hasselmann J, et al. (2023) Author Correction: Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease. Nature Communications. 14: 1194 |
| Chadarevian JP, Lombroso SI, Peet GC, et al. (2022) Engineering an inhibitor-resistant human CSF1R variant for microglia replacement. The Journal of Experimental Medicine. 220 |
| Kiani Shabestari S, Morabito S, Danhash EP, et al. (2022) Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice. Cell Reports. 39: 110961 |
| Zagorski K, Chailyan G, Hovakimyan A, et al. (2022) Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein. International Journal of Molecular Sciences. 23 |